Synthesis, in vivo effects, metabolism, and excretion of 5-(p-hydroxyanilino)-1,2,3,4-thiatriazole in the beagle dog.
D000284:Administration, Oral; D000814:Aniline Compounds / Q000008:administration & dosage / Q000097:blood / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use / Q000652:urine; D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000097:blood / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use / Q000652:urine; D001794:Blood Pressure / Q000187:drug effects; D002855:Chromatography, Thin Layer; D004285:Dogs; D004562:Electrocardiography; D005243:Feces / Q000032:analysis; D005260:Female; D006207:Half-Life; D006339:Heart Rate / Q000187:drug effects; D006977:Hypertension, Renal / Q000188:drug therapy; D008297:Male; D011865:Radioisotope Dilution Technique; D012119:Respiration / Q000187:drug effects; D013844:Thiazoles / Q000008:administration & dosage / Q000097:blood / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use / Q000652:urine; D013997:Time Factors; D014316:Tritium
D000814:Aniline Compounds; D000959:Antihypertensive Agents; D013844:Thiazoles; D014316:Tritium